Bank of America’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bank of America’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-357,507	Closed	-$14.7M	–	7716
2015 Q2	$14.7M	Buy	357,507 +311,476	+677%	+$11.2M	﹤0.01%	1636
2015 Q1	$1.62M	Sell	46,031 -11,409	-20%	-$386K	﹤0.01%	3413
2014 Q4	$1.84M	Buy	57,440 +10,523	+22%	+$304K	﹤0.01%	3469
2014 Q3	$1.32M	Sell	46,917 -3,312	-7%	-$101K	﹤0.01%	3766
2014 Q2	$1.52M	Sell	50,229 -18,570	-27%	-$513K	﹤0.01%	3616
2014 Q1	$1.9M	Sell	68,799 -100,032	-59%	-$2.62M	﹤0.01%	3260
2013 Q4	$4.31M	Sell	168,831 -167,182	-50%	-$5.15M	﹤0.01%	2605
2013 Q3	$10M	Buy	336,013 +37,675	+13%	+$1.05M	﹤0.01%	1784
2013 Q2	$8.58M	Buy	+298,338	New	+$8.22M	﹤0.01%	1848

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Bank of America's BRLI Position: Q3 2015 in Review

Bank of America sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 357,507 shares — an estimated $14.7M sold.

Bank of America first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $14.7M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Bank of America reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Bank of America sold 357,507 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $14.7M.
Bank of America first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Bank of America's BIO-REFERENCE LABS INC-NEW- position peaked at $14.7M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Bank of America's 13F filing for Q3 2015, filed 16 Nov 2015.